Expanded Application of a Photoaffinity Probe to Study Epidermal Growth Factor Receptor Tyrosine Kinase with

Hui Deng1,2, Qian Lei1,2, Na Yang1,2

  • 1Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

Analytical Chemistry
|June 22, 2022
PubMed

Insights

Researchers developed a photoaffinity probe (HX101) to study epidermal growth factor receptor (EGFR) activity in cells and tissues. This tool aids in visualizing EGFR activation and predicting cancer treatment response.

Area of Science:

  • Chemical Biology
  • Molecular Oncology
  • Biotechnology

Background:

  • Abnormal epidermal growth factor receptor (EGFR) activation drives cancer progression, necessitating tools for its study.
  • Current methods for visualizing EGFR activity in native environments are limited.
  • EGFR tyrosine kinase inhibitors (EGFR-TKIs) are crucial cancer therapeutics, but their sensitivity varies.

Purpose of the Study:

  • To develop a novel photoaffinity probe for quantitative analysis and visualization of EGFR kinase activity.
  • To enable multi-modal assessment of EGFR activation in cellular and tissue contexts.
  • To explore the probe's utility in predicting EGFR-TKI sensitivity in lung cancer patients.

Main Methods:

  • Design and synthesis of a two-step photoaffinity probe (HX101) incorporating a diazirine and an alkyne.
  • Utilizing click chemistry to attach reporter groups (fluorophore, biotin) for detection.
  • Application of HX101 in flow cytometry, confocal microscopy, super-resolution imaging, and mass spectrometry.

Main Results:

  • HX101 covalently targets and labels active EGFR upon photoactivation in cancer cells and human tissue slices.
  • The probe facilitates visualization and target engagement studies of EGFR across various analytical platforms.
  • HX101 successfully visualized EGFR mutant activity in lung cancer patient tissues, correlating with EGFR-TKI sensitivity.

Conclusions:

  • The developed photoaffinity probe (HX101) is a versatile tool for multi-modal assessment of EGFR activity.
  • HX101 enables visualization of EGFR activation in live cells and patient-derived tissues.
  • This probe holds potential for advancing cancer research and clinical applications, including predicting therapeutic response.